BRIDGEWAY CAPITAL MANAGEMENT, LLC - AVEO PHARMACEUTICALS INC ownership

AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 51 filers reported holding AVEO PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of AVEO PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2018$554,000
-51.7%
346,4640.0%0.01%
-36.4%
Q3 2018$1,147,000
+46.5%
346,4640.0%0.01%
+37.5%
Q2 2018$783,000
-22.1%
346,4640.0%0.01%
-27.3%
Q1 2018$1,005,000
+3.9%
346,4640.0%0.01%
+10.0%
Q4 2017$967,000
-23.6%
346,4640.0%0.01%
-28.6%
Q3 2017$1,265,000
+23.7%
346,464
-24.8%
0.01%
+16.7%
Q2 2017$1,023,000
+276.1%
460,9640.0%0.01%
+300.0%
Q1 2017$272,000
+9.2%
460,9640.0%0.00%0.0%
Q4 2016$249,000
-45.6%
460,964
-10.3%
0.00%
-57.1%
Q3 2016$458,000
-7.3%
514,0510.0%0.01%
-12.5%
Q2 2016$494,000
+70.9%
514,051
+63.7%
0.01%
+60.0%
Q1 2016$289,000
-27.0%
314,0510.0%0.01%
-28.6%
Q4 2015$396,000
+68.5%
314,051
+61.5%
0.01%
+40.0%
Q3 2015$235,000
-30.5%
194,5000.0%0.01%
-28.6%
Q2 2015$338,000
+19.9%
194,5000.0%0.01%
+16.7%
Q1 2015$282,000
+86.8%
194,500
+8.1%
0.01%
+100.0%
Q4 2014$151,000
-24.5%
180,0000.0%0.00%
-40.0%
Q3 2014$200,000
+263.6%
180,000
+500.0%
0.01%
+400.0%
Q2 2014$55,000
-94.8%
30,000
-94.8%
0.00%
-96.9%
Q4 2013$1,061,000
-11.2%
580,0000.0%0.03%
-22.0%
Q3 2013$1,195,000
+8.6%
580,000
+31.8%
0.04%
-6.8%
Q2 2013$1,100,000440,0000.04%
Other shareholders
AVEO PHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
Greylock XI GP Limited Partnership 584,004$1,068,000100.00%
GREAT POINT PARTNERS LLC 2,325,000$4,255,0001.89%
Sarissa Capital Management LP 2,570,759$4,704,0001.60%
Deer VI & Co. LLC 675,242$1,236,0000.68%
Palo Alto Investors LP 1,200,800$2,197,0000.16%
Baupost Group 3,829,350$7,008,0000.11%
Gruss Capital Management LP 533,253$976,0000.05%
Granahan Investment Management 676,451$1,238,0000.04%
Fore Research & Management, LP 674,200$1,233,0000.04%
TFS CAPITAL LLC 210,369$385,0000.03%
View complete list of AVEO PHARMACEUTICALS INC shareholders